Food-related gastrointestinal symptoms, nutrient intake and dietary interventions in patients with irritable bowel syndrome

dc.contributor.authorBöhn, Lena
dc.date.accessioned2015-01-09T08:42:14Z
dc.date.available2015-01-09T08:42:14Z
dc.date.issued2015-01-09
dc.description.abstractFood is a recurrent problem in irritable bowel syndrome (IBS) and it is common to exclude foods, which could lead to a reduced nutrient intake. Perceived food intolerance is very common in IBS, but if specific or more generalized food intolerance is the problem is unknown. Incompletely absorbed carbohydrates (fermentable oligo-, di-, mono-saccharides and polyols, FODMAPs) can trigger gastrointestinal (GI) symptoms, but if an enzyme (α-galactosidase), capable of digesting oligosaccharides, is able to relieve meal-related symptoms, or if a diet low in FODMAPs is more efficient in reducing symptoms than traditional dietary advice is not known. Methods: Paper 1: The nutrient intake (from food diaries) in IBS patients was compared with a sex-and-age matched population from a Swedish national dietary survey. Paper 2: IBS patients completed questionnaires to assess self-reported food intolerance and the association with other clinical and demographic variables. Paper 3: In a randomized, double-blind, placebo-controlled, crossover trial; the effect of α-galactosidase on GI symptoms in IBS patients after carbohydrate-rich meals was investigated. Paper 4: In a randomized, single-blind, parallel group, four-week trial; the effect on IBS symptoms of a low FODMAPs diet was compared with traditional dietary advice in IBS. Main results: The nutrient intake in IBS patients was similar to the Swedish general population. Eighty-four percent of IBS patients reported food-related GI symptoms, especially after intake of foods rich in incompletely absorbed carbohydrates and fat. Self-reported food intolerance was associated with more severe IBS symptoms and reduced quality of life. α-galactosidase was not superior to placebo in reducing GI symptoms after carbohydrate-rich meals in IBS patients. Fifty percent in the low FODMAPs group responded favorably to the dietary intervention (reduced GI symptoms), and 46 % were responders in the group who received traditional dietary advice. Conclusions: Despite a high degree of self-reported food intolerance in IBS, the majority of these patients seem to have adequate nutrient intake. A low FODMAPs diet and traditional IBS dietary advice, but not α-galactosidase capsules, reduce symptom burden in patients with IBS.sv
dc.gup.defencedate2015-01-30
dc.gup.defenceplaceFredagen den 30 januari 2015, kl. 9.00, Hörsal Björn Folkow, Medicinaregatan 9 bsv
dc.gup.departmentInst of Medicine. Department of Internal Medicine and Clinical Nutritionsv
dc.gup.dissdb-fakultetSA
dc.gup.maillena@bohns.sesv
dc.gup.originUniversity of Gothenburg. Sahlgrenska Academysv
dc.identifier.isbn978-91-628-9245-6 (printed)
dc.identifier.isbn978-91-628-9248-7 (electronic)
dc.identifier.urihttp://hdl.handle.net/2077/37527
dc.language.isoengsv
dc.relation.haspartI. Böhn L et al. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol Motil. 2013;25(1):23-30.e1. ::doi:: 10.1111/nmo.12001sv
dc.relation.haspartII. Böhn L et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634-41. :: doi:: 10.1038/ajg.2013.105sv
dc.relation.haspartIII. Böhn L et al. A randomized double-blind placebo-controlled study: Effects of the enzyme alpha-Galactosidase on gastrointestinal symptoms in IBS patients. Submitted for publication.sv
dc.relation.haspartIV. Böhn L et al. A randomized, controlled trial comparing a diet low in FODMAPs with traditional dietary advice in patients with IBS. Submitted for publication.sv
dc.subjectirritable bowel syndromesv
dc.subjectgastrointestinal symptomssv
dc.subjectdietsv
dc.titleFood-related gastrointestinal symptoms, nutrient intake and dietary interventions in patients with irritable bowel syndromesv
dc.typetexteng
dc.type.degreeDoctor of Philosophy (Medicine)sv
dc.type.svepDoctoral thesiseng

Files

Original bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
gupea_2077_37527_1.pdf
Size:
6.52 MB
Format:
Adobe Portable Document Format
Description:
Thesis frame
No Thumbnail Available
Name:
gupea_2077_37527_2.pdf
Size:
347.31 KB
Format:
Adobe Portable Document Format
Description:
Abstract

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.68 KB
Format:
Item-specific license agreed upon to submission
Description: